# MAZE THERAPEUTICS INC (MAZE)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/MAZE/

- Reporting holders: 3
- Reported value: $18.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $8.9K | 327 | 0.0% | 5 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $5.5K | 202 | 0.0% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $4.3K | 158 | 0.0% | 6 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $18.7K |
| Q2 2026 | 164 | $1.8B |
| Q1 2026 | 168 | $1.6B |
| Q4 2025 | 146 | $2.0B |
| Q3 2025 | 95 | $1.1B |
| Q2 2025 | 75 | $476.7M |
| Q1 2025 | 67 | $374.5M |